Adjusted post-AC mean LVEF in patients with lymphoma with and without CAD
| CAD | Pre-LVEF (%) | Adjusted post-LVEF mean (%) | 95% CI |
|---|---|---|---|
| Yes (n=12) | All, mean=59 | 47 | (41 to 53) |
| 45 | 36 | (27 to 45) | |
| 55 | 43 | (37 to 49) | |
| 65 | 50 | (43 to 56) | |
| No (n=61) | All, mean=62 | 54 | (52 to 57) |
| 45 | 58 | (49 to 67) | |
| 55 | 56 | (51 to 60) | |
| 65 | 53 | (50 to 56) |
The median years on study for survivors were 2.99 years.
AC, anthracycline-based chemotherapy; CAD, coronary artery disease; LVEF, left ventricular ejection fraction.